NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application

NanoViricides has signed a consulting agreement with Biologics Consulting Group (BCG) in order to prepare and submit the Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for approval of its nanoviricides drug candidates to treat different viral diseases.

The success of FluCide drug candidates in pre-medical animal studies has already been reported by NanoViricides. The company is involved in the preparation of FluCide investigational anti-influenza drug. The company will receive guidance from BCG regarding filling of the pre-IND application to successfully complete FDA approval and evaluation process. BCG will assist NanoViricides in scheduling and applying extra pre-clinical development activities that are required for the IND application.

Additionally, the company expects that while submitting the first IND application to the FDA, it should have produced some amount of drug candidates associated to the product under current Good Manufacturing Practices (cGMP) conditions. The company has declared that it will be leasing facilities so as to be able tomeet the cGMP requirements in a specified period.

BCG, an international consulting organization provides guidance about both national and international regulations and helps in commercial developmental processes for producing drug, device, and biological products. BCG has knowledge in product production and testing, facility inspections, regulatory affairs, pharmacology, toxicology, medical trial design and assessment, statistics, and program management.

Source: www.nanoviricides.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application. AZoNano. Retrieved on February 18, 2020 from https://www.azonano.com/news.aspx?newsID=22898.

  • MLA

    Chai, Cameron. "NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application". AZoNano. 18 February 2020. <https://www.azonano.com/news.aspx?newsID=22898>.

  • Chicago

    Chai, Cameron. "NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application". AZoNano. https://www.azonano.com/news.aspx?newsID=22898. (accessed February 18, 2020).

  • Harvard

    Chai, Cameron. 2019. NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application. AZoNano, viewed 18 February 2020, https://www.azonano.com/news.aspx?newsID=22898.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit